Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Dapsone

80-08-0C12H12N2O2S248.307 g/mol

A sulfone that is diphenylsulfone in which the hydrogen atom at the 4 position of each of the phenyl groups is substituted by an amino group. It is active against a wide range of bacteria, but is mainly employed for its actions against Mycobacterium leprae, being used as part of multidrug regimens in the treatment of all forms of leprosy. — ChEBI

Safety references

Safety documents & references

1 indexed references
JP · NITE

Government GHS classification

20A2010 · FY2008

View classification

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number80-08-0ChEBI ↗
Molecular formulaC12H12N2O2SChEBI ↗
Molar mass248.307 g/molChEBI ↗
Monoisotopic mass248.06195 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:4325ChEBI ↗

Cross-source molecular data

PubChem
Molar mass248.30 g/molPubChem ↗
Exact mass248.06194880 DaPubChem ↗
Computed XLogP1PubChem ↗
Topological polar surface area (Ų)94.6PubChem ↗
H-bond donors2PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds2PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
dapsone
4,4'-sulfonyldianiline
MQJKPEGWNLWLTK-UHFFFAOYSA-N
Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1
InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2

Names & synonyms

4,4'-sulfonyldianilinedapsonadapsonum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antiviral agentantifibrotic agentantiinfective agentanti-inflammatory drugantineoplastic agentantifungal agentleprostatic drugantimalarialdermatologic druganti-HIV agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety classification · Japan

NITE / Japanese government
Japan · FY2008 source classification
dapsone; 4,4'-diamino diphenyl sulfone · 20A2010
EndpointReported classification
Acute toxicity (Oral)Category 4
Specific target organ toxicity - Repeated exposureCategory 1 (blood)

Selected source-reported endpoints. Other endpoints, rationales and conditions remain in the original classification. Missing or unlisted information does not mean non-hazardous. This is not a global classification or transport decision.

Read the original NITE classification

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00402727 mol

Uses 248.307 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 12 atoms
58.05%
S
Sulfur · 1 atom
12.92%
O
Oxygen · 2 atoms
12.89%
N
Nitrogen · 2 atoms
11.28%
H
Hydrogen · 12 atoms
4.87%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Dapsone hypersensitivity syndrome: a clinico-epidemiological review. ↗The Journal of dermatology · 2005 Nov · PMID 16361748
FR829926 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:4325

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 2955 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.